Global Genomics Biomarkers Market Trends and Forecasts 2017-2021

Report : Global Genomics Biomarkers Market 2017-2021 is a new market research publication announced by Reportstack. 

Report Outline: A measurable DNA and/or RNA characteristic is an indicator of normal biologic processes, pathogenic processes, and/or response to a therapeutic or other interventions. A genomic biomarker can be used for measuring the expression, function, and regulation of a gene. These biomarkers have characteristics of one or more deoxyribonucleic acid (DNA) and/or ribonucleic acid (RNA).

For detailed report with TOC, please click here ​Global Genomics Biomarkers Market 2017-2021

Market Growth: The global genomics biomarkers market to grow at a CAGR of 17.59% during the period 2017-2021.

Key vendors • Roche Diagnostics
• Myriad Genetics
• QIAGEN
• Thermo Fisher Scientific
• Bio-Rad Laboratories

Other prominent vendors • 23andMe
• Aepodia
• Almac Group 
• AROS Applied Biotechnology
• DNAVision
• Epigenomics
• Epistem
• Eurofins Scientific
• Foundation Medicine
• Genomic Health
• Liquid Genomics
• New England Biolabs
• OriGene
• US Biomarkers

Regions Covered:

• Americas
• APAC
• EMEA

Companies Mentioned

Roche Diagnostics, Myriad Genetics, QIAGEN, Thermo Fisher Scientific, Bio-Rad Laboratories, 23andMe, Aepodia, Almac, AROS Applied Biotechnology, DNAVision, Epigenomics, Epistem, Eurofins Scientific, Foundation Medicine, Genomic Health, Liquid Genomics, New England Biolabs, OriGene, US Biomarkers.

Contact:

Debora White

Manager - Marketing

debora@reportstack.com

Ph: +1-888-789-6604

Reportstack Market Research

###